Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Momenta Pharmaceuticals Inc. (MNTA)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: MNTA
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Top Authors
Most frequent coverage on MNTA
Mike Havrilla
(1946 followers)
Momenta Pharma's M-Enoxaparin: Timing Uncertain, Approval Likely
(Wed, Oct 7)
Biotech News Bytes: Genzyme, ImmunoCellular, Momenta, Novo Nordisk
(Wed, Sep 23)
BioMed News Bytes: Arena, Momenta, Vivus
(Sun, Sep 20)
More by Mike Havrilla on MNTA »
Bespoke Investment Group
(3555 followers)
Best and Worst Performing Stocks Seven Months Into 2008
(Mon, Aug 4)
Another Month of '08 in the Books
(Thu, May 1)
Q1's Best and Worst Performing Stocks
(Tue, Apr 1)
More by Bespoke Investment Group on MNTA »
Centient Biotech Investor
(10 followers)
Biotech Day In Review: Sanofi Loses Lovenox Patent
(Sun, Feb 11)
More by Centient Biotech Investor on MNTA »
Most followed authors on MNTA
Bespoke Investment Group
(3555 followers)
Best and Worst Performing Stocks Seven Months Into 2008
(Mon, Aug 4)
Another Month of '08 in the Books
(Thu, May 1)
Q1's Best and Worst Performing Stocks
(Tue, Apr 1)
More by Bespoke Investment Group on MNTA »
Mike Havrilla
(1946 followers)
Momenta Pharma's M-Enoxaparin: Timing Uncertain, Approval Likely
(Wed, Oct 7)
Biotech News Bytes: Genzyme, ImmunoCellular, Momenta, Novo Nordisk
(Wed, Sep 23)
BioMed News Bytes: Arena, Momenta, Vivus
(Sun, Sep 20)
More by Mike Havrilla on MNTA »
Marco Hickey
(1317 followers)
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
(Sun, Jun 28)
More by Marco Hickey on MNTA »
Newest authors on MNTA
M. E. Garza
(522 followers)
Big Movers in Healthcare - JAZZ, HEB, MNTA, MBLX and OCLS
(Sun, Jun 28)
More by M. E. Garza on MNTA »
The Burrill Report
(207 followers)
Sanofi Pulls the Plug on Two Drugs: Biotech's Latest Mishaps
(Thu, Dec 24)
More by The Burrill Report on MNTA »
Marco Hickey
(1317 followers)
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
(Sun, Jun 28)
More by Marco Hickey on MNTA »
Most commented on MNTA
Mike Havrilla
(1946 followers)
Momenta Pharma's M-Enoxaparin: Timing Uncertain, Approval Likely
(Wed, Oct 7)
Biotech News Bytes: Genzyme, ImmunoCellular, Momenta, Novo Nordisk
(Wed, Sep 23)
BioMed News Bytes: Arena, Momenta, Vivus
(Sun, Sep 20)
More by Mike Havrilla on MNTA »
M. E. Garza
(522 followers)
Big Movers in Healthcare - JAZZ, HEB, MNTA, MBLX and OCLS
(Sun, Jun 28)
More by M. E. Garza on MNTA »
Bespoke Investment Group
(3555 followers)
Best and Worst Performing Stocks Seven Months Into 2008
(Mon, Aug 4)
Another Month of '08 in the Books
(Thu, May 1)
Q1's Best and Worst Performing Stocks
(Tue, Apr 1)
More by Bespoke Investment Group on MNTA »